Ultra-low Dose Subcutaneous IL-2 in Renal Transplantation

NCT02417870 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped lack of funding/resources

Conditions

Kidney Transplantation

Interventions

BIOLOGICAL: aldesleukin

Sponsor

Anil K. Chandraker, MD